Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting
Washington, DC (PRWEB) June 03, 2015 -- Justina Molzon, MS Pharm, JD will be honored with a Global Inspire Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes the organization’s outstanding volunteers for their leadership, level of excellence, and commitment to service on a global scale.
Molzon will receive the Excellence in Service Award that recognizes the “Member of the Year” who consistently provides outstanding service as a DIA volunteer and who has contributed to the advancement of DIA’s mission.
“We thank Justina for her years of service dedicated to improving public health and safety,” said Barbara Lopez Kunz, DIA global chief executive. “We are honored to recognize her many contributions to DIA and look forward to continuing to benefit from her knowledge and experience as a dedicated DIA volunteer.”
Molzon served as the Associate Center Director for International Programs at the Center for Drug Evaluation and Research (CDER), part of the U.S. Food and Drug Administration (FDA) and was a member of CDER’s senior staff. She is a recently retired commissioned officer in the U.S. Public Health Service and is a pharmacist and attorney. While at CDER, she coordinated the organization’s efforts related to the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) and the President’s Emergency Plan for Aids Relief (PEPFAR). Molzon actively participates in DIA’s educational platform in several teaching and speaking capacities and serves as a member of the editorial board of DIA’s digital member magazine, Global Forum, serving as content editor for laws and regulations.
DIA’s annual Inspire Awards nominees must demonstrate a record of outstanding commitment to raising the level of health and well-being worldwide. For more information about DIA’s Inspire Award program, click here.
Registration is open to attend DIA’s 2015 51st Annual Meeting in Washington, D.C. June 14-18. Follow DIA’s Twitter feed (@DrugInfoAssn) and #DIA2015 for news about DIA 2015 51st Annual Meeting.
About DIA
For over 50 years, DIA has served as a global platform for more than 30,000 health care product development professionals, researchers, regulators, clinicians, academics and patient advocates to collaborate to improve health globally through the advancement of lifesaving medicines and technologies. As the premier professional community for the health care product development ecosystem, DIA (the Drug Information Association) provides global players a neutral and transparent forum for the exchange of ideas and collaboration. By offering access to tools, resources, and networking opportunities, DIA provides its members and international participants objective opportunities for extending debate and discussion to advance scientific and medical innovation.
DIA is an independent, global nonprofit organization based in Washington, DC, USA, with regional offices representing the Americas (Horsham, PA, USA); Europe, Africa and the Middle East (Basel, Switzerland); and Asia (Beijing, China; Mumbai, India; and, Tokyo, Japan). For more information, visit our website at http://www.DIAGlobal.org or contact us via Twitter @DrugInfoAssn, LinkedIn or on Facebook.
About DIA’s 2015 Annual Meeting
The DIA 2015 51st Annual Meeting brings together a 7,000+ community of life sciences professionals at all levels and across all disciplines from around the globe that are involved in the discovery, development and life cycle management of medical products. Follow Annual Meeting news on Twitter using #DIA2015.
Melissa Warren, inVentiv Health, +1 (202) 609-6010, [email protected]
Share this article